Close Window Contributors Editor Kent R. Olson, MD, FACEP, FACMT, FAACT Clinical Professor of Medicine, Pediatrics, and Pharmacy, University of California, San Francisco; Medical Director, California Poison Control System, San Francisco Division Associate Editors Ilene B. Anderson, PharmD Clinical Professor of Pharmacy, University of California, San Francisco; Senior Toxicology Management Specialist, California Poison Control System, San Francisco Division Neal L. Benowitz, MD Professor of Medicine and Chief, Division of Clinical Pharmacology and Toxicology, University of California, San Francisco; Associate Medical Director, California Poison Control System, San Francisco Division Paul D. Blanc, MD, MSPH Professor of Medicine and Chief, Division of Occupational and Environmental Medicine, University of California, San Francisco Richard F. Clark, MD, FACEP Professor of Medicine, University of California, San Diego; Director, Division of Medical Toxicology and Medical Director, California Poison Control System, San Diego Division Thomas E. Kearney, PharmD, ABAT Professor of Clinical Pharmacy, University of California, San Francisco; Managing Director, California Poison Control System, San Francisco Division John D. Osterloh, MD, MS Chief Medical Officer, Division of Laboratory Sciences National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia Contributors Timothy E. Albertson, MD, PhD Professor of Medicine, Medical Pharmacology and Toxicology, University of California Medical Center, Davis; Medical Director, California Poison Control System, Sacramento Division [email protected] Section II: Amphetamines; Barbiturates; Dextromethorphan; Opiates and Opioids Judith A. Alsop, PharmD, DABAT Associate Clinical Professor, School of Pharmacy, University of California, San Francisco; Clinical Professor of Medicine, School of Medicine, University of California, Davis [email protected] Section II: Plants; Section III: Metoclopramide; Ondansetron; Potassium Ilene B. Anderson, PharmD Clinical Professor, School of Pharmacy, University of California, San Francisco; Senior Toxicology Management Specialist, California Poison Control System, San Francisco Division [email protected] Section II: Botulism; Camphor and Other Essential Oils; Ethylene Glycol and Other Glycols; Lomotil and Other Antidiarrheals; Methanol; Warfarin and Related Rodenticides John Balmes, MD Professor, Department of Medicine, University of California, San Francisco; Chief, Division of Occupational and Environmental Medicine, San Francisco General Hospital [email protected] Section II: Asbestos; Formaldehyde; Gases, Irritant; Molds; Phosgene; Sulfur Dioxide Neal L. Benowitz, MD Professor of Medicine and Chief, Division of Clinical Pharmacology and Toxicology, University of California, San Francisco; Associate Medical Director, California Poison Control System, San Francisco Division [email protected] Section II: Anesthetics, Local; Antiarrhythmic Drugs; Antidepressants, General (Noncyclic); Antidepressants, Tricyclic; Beta-Adrenergic Blockers; Calcium Antagonists; Cardiac Glycosides; Chloroquine and Other Aminoquinolines; Cocaine; Ergot Derivatives; Lithium; Marijuana; Monoamine Oxidase Inhibitors; Nicotine; Nitrates and Nitrites; Nitroprusside; Phencyclidine (PCP) and Ketamine; Pseudoephedrine, Phenylephrine and Other Decongestants; Quinidine and Other Type IA Antiarrhythmic Drugs; Quinine; Vacor (PNU); Section III: Dopamine; Epinephrine; Norepinephrine David P. Betten Assistant Clinical Professor, Department of Emergency Medicine, College of Human Medicine, Michigan State University, East Lansing [email protected] Section II: Colchicine Kathleen Birnbaum, PharmD Toxicology Management Specialist, Department of Clinical Pharmacy, University of California, San Francisco [email protected] Section III: Insulin; Leucovorin Calcium Paul D. Blanc, MD, MSPH Professor of Medicine, and Chief, Division of Occupational and Environmental Medicine, University of California, San Francisco [email protected] Section II: Carbon Disulfide; Cyanide; Isocyanates; Manganese; Metal Fume Fever; Methemoglobinemia; Nitrogen Oxides; Section IV: Evaluation of the Patient with Occupational Chemical Exposure; The Toxic Hazards of Industrial and Occupational Chemicals Stephen C. Born, MD, MPH Associate Clinical Professor, Division of Occupational and Environmental Medicine, University of California, San Francisco [email protected] Section II: Dioxins, Ethylene Oxide Alan Buchwald, MD Consultant in Medical Toxicology and Medical Director, Occupational Health Center, Dominican Santa Cruz Hospital, Santa Cruz, California [email protected] Section II: Copper Cindy Burkardt Toxicology Management Specialist, California Poison Control System, San Francisco Division [email protected] Section III: DTPA; Thiosulfate, Sodium Chris Camilleri, DO Attending Physician, University of California Davis Medical Center, Sacramento. Section II: Benzene F. Lee Cantrell, PharmD Assistant Clinical Professor, School of Pharmacy, University of California, San Diego and San Francisco; Interim Director, California Poison Control System, San Diego Division [email protected] Section II: Thyroid Hormone; Section III: Cyproheptadine; Folic Acid; Inamrinone (formerly Amrinone) Terry Carlson, PharmD Toxicology Management Specialist, California Poison Control System, Fresno/Madera Division [email protected] Section III: Naloxone and Nalmefene Richard F. Clark, MD Professor of Medicine, University of California, San Diego; Director, Division of Medical Toxicology, University of California Medical Center, San Diego; Medical Director, California Poison Control System, San Diego Division [email protected] Section II: Hymenoptera; Lionfish and Other Scorpaenoidea; Scorpions; Snakebite; Section III: Antivenom, Crotalinae (Rattlesnake); Antivenom, Latrodectus Mactans (Black Widow Spider); Antivenom, Micrurus Fulvius (Coral Snake), and Exotic Antivenoms Matthew D. Cook Assistant Clinical Professor, Medical Toxicology Fellow, and Attending Physician, Department of Emergency Medicine, University of California Medical Center, San Diego [email protected] Section II: Phosphorus Delia A. Dempsey, MD, MS Assistant Adjunct Professor of Pediatrics, Medicine, and Clinical Pharmacy, University of California, San Francisco; Assistant Medical Director, California Poison Control System, San Francisco Division [email protected] Section I: Special Considerations in Pediatric Patients; Section II: Bromides; Methyl Bromide; Pentachlorophenol and Dinitrophenol Jo Ellen Dyer, PharmD Clinical Professor, Department of Pharmacy, University of California, San Francisco; Senior Toxicology Management Specialist, California Poison Control System, San Francisco Division [email protected] Section I: Special Considerations in the Evaluation of Drug-Facilitated Assault; Section II: Azide, Sodium; Gamma- Hydroxybutyrate (GHB) Andrew Erdman, MD Clinical Pharmacology Fellow, University of California, San Francisco [email protected] Section II: Isoniazid (INH) Gary W. Everson, PharmD Toxicology Management Specialist, California Poison Control System, Fresno/Madera Division [email protected] Section II: Phenol and Related Compounds; Section III: Mannitol Jeffrey Fay, PharmD Assistant Clinical Professor, Department of Pharmacy, University of California, San Francisco; Toxicology Management Specialist, California Poison Control System, Fresno/Madera Division [email protected] Section II: Vasodilators Thomas J. Ferguson, MD, PhD Associate Clinical Professor of Internal Medicine, University of California, Davis; Medical Director, Cowell Student Health Center, University of California, Davis [email protected] Section II: Chromium; Thallium Frederick Fung, MD, MS Clinical Professor of Occupational Medicine, University of California, Irvine; Medical Director, Occupational Medicine Department and Toxicology Services, Sharp Rees-Stealy Medical Group, San Diego, California [email protected] Section II: Carbon Tetrachloride and Chloroform Mark J. Galbo, MS Environmental Toxicologist, School of Pharmacy, University of California, San Francisco; Poison Information Specialist, California Poison Control System, San Francisco Division [email protected] Section II: Naphthalene and Paradichlorobenzene; Warfare Agents—Chemical Fabian Garza, PharmD School of Pharmacy, University of California, San Francisco; Toxicology Management Specialist, California Poison Control System, Fresno/Madera Division [email protected] Section III: Methylene Blue Richard J. Geller, MD, MPH Associate Clinical Professor of Emergency Medicine, University of California, San Francisco; Medical Director, California Poison Control System, Fresno/Madera Division Section II: Disulfiram; Paraquat and Diquat; Selenium; Section III: Atropine and Glycopyrrolate; Pralidoxime (2- PAM) & Other Oximes Robert L. Goldberg, MD, FACOEM Director, Occupational and Environmental Medicine Residency Program; Health Sciences Associate Clinical Professor of Medicine, Department of Medicine, University of California, San Francisco [email protected] Section II: Polychlorinated Biphenyls (PCBs) Colin S. Goto, MD Assistant Clinical Professor of Pediatrics, University of California, San Diego; Attending Physician, Division of Emergency Medicine, Children's Hospital and Health Center, San Diego, California [email protected] Section II: Hydrocarbons Christine A. Haller, MD Assistant Professor of Medicine